Table 1.
Clinical and laboratory characteristics of patients with dcSSc.
| Characteristic | ||
|---|---|---|
| Age (years)a | 56.45±13.60 | |
| Sex | Male | 2 (7.14) |
| Female | 26 (92.86) | |
| SSc duration (years)b | 6 (1–25) | |
| Autoantibody pattern | Antinuclearc | 2 (7.14) |
| Anticentromere | 8 (28.57) | |
| Anti-Scl70 | 18 (64.29) | |
| Hemoglobin (g/dL)a | 13.8±2.2 | |
| Creatinine (mg/dL)a | 0.83±0.21 | |
| Erythrocyte sedimentation rate(normal >24 mm/hour) | Normal | 16 (38.1) |
| High | 26 (61.9) | |
| mRSS | Normal | 0 (0) |
| Mild/moderate | 20 (71.42) | |
| Severe/end-stage | 8 (28.58) | |
| Gastrointestinal tract | Absent | 8 (28.58) |
| Mild/moderate | 19 (67.85) | |
| Severe/end-stage | 1 (3.57) | |
| Joint/tendon | Normal | 4 (14.28) |
| Mild/moderate | 23 (82.14) | |
| Severe/end-stage | 1 (3.57) | |
| Muscle | Normal | 7 (25.01) |
| Mild/moderate | 20 (71.42) | |
| Severe/end-stage | 1 (3.57) | |
| Digital ulcers | Absent | 26 (92.85) |
| Present | 2 (7.15) | |
| Peripheral vascular involvement | Absent | 4 (14.28) |
| Mild/moderate | 24 (85.72) | |
| Severe/end-stage | 0 (0.00) | |
| Lung involvement | Absent | 3 (10.71) |
| Mild/moderate | 24 (85.72) | |
| Severe/end-stage | 1 (3.57) | |
| Chest radiography | Normal | 19 (67.85) |
| Interstitial lung disease | 9 (32.15) | |
| Heart involvement | Absent | 7 (25.01) |
| Mild/moderate | 20 (71.42) | |
| Severe/end-stage | 1 (3.57) |
Data expressed as absolute number (%) unless otherwise indicated.
aValues expressed as mean ± SD.
bValues expressed as median (range).
cWithout anticentromere antibodies and anti-Scl70 antibodies.
Abbreviations: dcSSc, diffuse cutaneous systemic sclerosis; mRSS, modified Rodnan skin score; SSc, systemic sclerosis; SD, standard deviation.